RSLSReShape Lifesciences Inc.

Nasdaq reshapelifesciences.com


$ 0.22 $ 0.01 (6.28 %)    

Thursday, 11-Jul-2024 15:51:20 EDT
QQQ $ 492.14 $ -11.98 (-2.38 %)
DIA $ 397.90 $ 0.34 (0.09 %)
SPY $ 556.42 $ -4.90 (-0.87 %)
TLT $ 93.53 $ 0.89 (0.96 %)
GLD $ 223.19 $ 3.83 (1.75 %)
$ 0.221
$ 0.20
$ 0.00 x 0
$ 0.00 x 0
$ 0.20 - $ 0.23
$ 0.14 - $ 1.66
3,130,572
na
4.86M
$ 1.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 04-17-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-19-2022 06-30-2022 10-Q
9 05-23-2022 03-31-2022 10-Q
10 04-08-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 06-19-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 07-24-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-05-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vyome-has-signed-a-merger-agreement-with-reshape-lifesciences-to-go-public-and-trade-on-the-nasdaq-capital-market-under-the-ticker-symbol-hind

Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global ma...

 reshape-lifesciences-receives-notice-of-allowance-for-us-patent-application-titled-intragastric-volume-occupying-device-and-method-for-fabricating-same-for-treating-obesity

https://patentcenter.uspto.gov/applications/16865242/ifw/docs

 why-reshape-lifesciences-stock-is-moving-higher-wednesday

ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application en...

 amid-ozempics-miracle-weight-loss-craze-this-company-peaked-over-100-in-tuesday-pre-market-after-receiving-us-patent-for-obesity-treatment

The approval comes at a time when global demand for weight loss drugs like Ozempic and WeGovy is increasing.

 reshape-lifesciences-has-received-a-notice-of-allowance-for-its-us-patent-application-17572387-titled-intragastric-device-for-treating-obesity

https://patentcenter.uspto.gov/applications/17572387/ifw/docs 

 reshape-lifesciences-has-received-fda-510k-clearance-for-reshape-calibration-tubes-and-gastric-balloon-suction-catheter

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K241039